Drug-dependent antibodies against the prodrug carbimazole do not react with the metabolite thiamazole.
Kroll
H
H
Giptner
A
A
Santoso
S
S
D000918:Antibody Specificity; D013956:Antithyroid Agents / Q000009:adverse effects / Q000276:immunology* / Q000493:pharmacokinetics; D001323:Autoantibodies / Q000276:immunology*; D001327:Autoimmune Diseases / Q000139:chemically induced / Q000276:immunology*; D001711:Biotransformation; D001792:Blood Platelets / Q000276:immunology*; D002231:Carbimazole / Q000009:adverse effects / Q000276:immunology* / Q000493:pharmacokinetics; D003429:Cross Reactions; D006801:Humans; D008713:Methimazole / Q000276:immunology*; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000276:immunology*; D011355:Prodrugs / Q000009:adverse effects* / Q000493:pharmacokinetics; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000139:chemically induced / Q000276:immunology*
D013956:Antithyroid Agents; D001323:Autoantibodies; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D011355:Prodrugs; D008713:Methimazole; D002231:Carbimazole